0G5F3ZZ
Destruction Paraganglion Extremity to No Qualifier with No Device, Percutaneous Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | 0 Medical and Surgical |
| Body System | G Endocrine System |
| Operation | 5 Destruction |
| Body Part | F Paraganglion Extremity |
| Approach | 3 Percutaneous |
| Device | Z No Device |
| Qualifier | Z No Qualifier |
Operation Definition
Physical eradication of all or a portion of a body part by the direct use of energy, force, or a destructive agent
Procedure Overview
Destruction procedures in the endocrine system eliminate abnormal or diseased tissue in a gland, such as a thyroid nodule, adrenal mass, or pituitary lesion, using energy sources like radiofrequency, laser, cryotherapy, or chemical agents rather than by cutting the tissue out. The gland or the surrounding tissue is not physically removed from the body; it is destroyed in place and the body absorbs or walls off the treated area over time.
This approach is often chosen for patients who are not good candidates for surgical removal, for smaller lesions that do not require full excision, or when preserving as much of the surrounding healthy gland tissue as possible is a priority, such as with certain benign thyroid nodules treated by ablation.
Anatomy & Axis Detail
Paraganglion Extremity
Paraganglion extremity tissue refers to chemoreceptor-related paraganglion cells found in the limbs, part of the diffusely distributed extra-adrenal paraganglion system rather than a single discrete gland. Destruction in place at this site is uncommon and is generally pursued when a paraganglioma or similar lesion arises in extremity soft tissue and the clinical decision favors ablative energy, such as radiofrequency or cryoablation, over surgical excision, for example because of the lesion's location near neurovascular structures in the limb. Because paraganglion tissue in an extremity is not a routinely encountered anatomic target, imaging confirmation of the lesion and its relationship to adjacent nerves and vessels is particularly important before applying destructive energy. Documentation should specify the extremity involved and the nature of the paraganglion lesion being treated to support accurate coding of this uncommon body part.
Approach: Percutaneous
Percutaneous describes entry by needle or instrument puncture through the skin or mucous membrane to reach the site of the procedure, without cutting the tissue open or using a visualizing scope. It differs from Open in that the site itself is never exposed, and from Percutaneous Endoscopic in that no endoscope is used to see internal structures. Common examples include needle biopsies and injections.
Coding & Documentation
The operative note should describe an energy-based or chemical method used to eradicate tissue in place, with no portion of the gland physically excised or taken out. Coders need to identify the exact energy source and gland involved, since the approach and device values depend on whether an image-guided percutaneous probe, an endoscopic device, or an open technique was used.
The most frequent error is coding Destruction when any portion of tissue was actually cut out and removed for pathology, which instead falls under Excision or Resection. When a biopsy is taken from the same lesion before it is ablated, that sampling should be coded separately as an Excision.